Expression and pharmacological modulation of visceral pain-induced conditioned place aversion in mice
Bagdas D, Muldoon P, AlSharari S, Carroll F, Negus S, Damaj M. Expression and pharmacological modulation of visceral pain-induced conditioned place aversion in mice. Neuropharmacology 2015, 102: 236-243. PMID: 26639043, PMCID: PMC5574195, DOI: 10.1016/j.neuropharm.2015.11.024.Peer-Reviewed Original ResearchMeSH Keywords3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-IsomerAnalgesics, OpioidAnimalsAnti-Inflammatory Agents, Non-SteroidalAvoidance LearningBehavior, AnimalKetoprofenMaleMiceMice, Inbred ICRMorphinePiperidinesReceptors, Opioid, kappaReceptors, Opioid, muTetrahydroisoquinolinesVisceral PainConceptsMu-opioid receptor agonist morphinePlace aversionOpioid receptor agonist morphineReceptor agonist morphineMale ICR micePlace aversion (CPA) testPreclinical mouse modelsCandidate analgesicsNonsteroidal anti-inflammatory drug ketoprofenAgonist morphineOpioid agonistsICR miceIntraperitoneal administrationAnti-inflammatory drug ketoprofenPreclinical studiesMouse modelPharmacological modulationAnimal modelsMorphinePainReversal abilityAversion testAversive behaviorMiceBiological mechanisms